Irrigation for indwelling catheters back on market
Renacidin Irrigation (Citric Acid, Glucono delta-Lactone, and Magnesium Carbonate) is once again available after a series of manufacturing issues resulted in the product being unavailable for over a year, according to United-Guardian, Inc., the product’s marketer.
Renacidin Irrigation (Citric Acid, Glucono delta-Lactone, and Magnesium Carbonate) is once again available after a series of manufacturing issues resulted in the product being unavailable for over a year, according to United-Guardian, Inc., the product’s marketer.
Renacidin Irrigation is used primarily to prevent and dissolve calcifications in indwelling catheters to keep them free flowing. It is also approved for use in dissolving certain types of kidney stones.
Production of the agent had been temporarily suspended due to regulatory and manufacturing issues experienced by United’s contract manufacturer. United said that the issues have been resolved and that shipments were scheduled to resume in the first week of November.
United-Guardian said it is also in the process of developing a new 30-mL single-dose unit of Renacidin that will make the product easier to use. The company anticipates FDA approval of the new product some time next year.
To get weekly news from the leading news source for urologists, subscribe to the Urology Times eNews.
AUA, SUFU publish 2024 guideline for idiopathic overactive bladder
April 25th 2024“This brand new guideline offers options for all patients with OAB with a focus on shared decision-making between patients with OAB and clinicians, as well as a personalized, tailored approach to care,” said Cameron and Smith.
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.
